Pages that link to "Q37383738"
Jump to navigation
Jump to search
The following pages link to HIV Nef protein causes endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells (Q37383738):
Displaying 31 items.
- HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatment (Q26777241) (← links)
- Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk? (Q26777866) (← links)
- Dependence of Golgi apparatus integrity on nitric oxide in vascular cells: implications in pulmonary arterial hypertension (Q30499465) (← links)
- The Role of Caveolin 1 in HIV Infection and Pathogenesis (Q32183747) (← links)
- HIV protein Nef causes dyslipidemia and formation of foam cells in mouse models of atherosclerosis (Q33775135) (← links)
- Pulmonary hypertension associated with HIV infection: pulmonary vascular disease: the global perspective (Q33899409) (← links)
- HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cells (Q33954940) (← links)
- Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction (Q35114722) (← links)
- Protein Trafficking Dysfunctions: Role in the Pathogenesis of Pulmonary Arterial Hypertension (Q35412349) (← links)
- Nordihydroguaiaretic acid (NDGA) inhibits ritonavir-induced endothelial dysfunction in porcine pulmonary arteries. (Q35743832) (← links)
- HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking (Q35848134) (← links)
- HIV-1, reactive oxygen species, and vascular complications (Q36040759) (← links)
- Pathogenesis of HIV and the lung (Q36863970) (← links)
- Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort (Q36629915) (← links)
- HIV stroke risk: evidence and implications (Q36722756) (← links)
- Human immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development (Q36810837) (← links)
- Inflammation, immune activation, and cardiovascular disease in HIV. (Q36957752) (← links)
- Infectious burden and atherosclerosis: A clinical issue. (Q37843968) (← links)
- The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension. (Q37851851) (← links)
- Risk of coronary heart disease in patients with HIV infection (Q38261508) (← links)
- HIV-1-Associated Atherosclerosis: Unraveling the Missing Link (Q39392100) (← links)
- Attenuation of nitric oxide bioavailability in porcine aortic endothelial cells by classical swine fever virus (Q40330263) (← links)
- Novel mediators of statin effects on plaque in HIV: a proteomics approach (Q49713177) (← links)
- EMAPII: A Key Player in HIV-Nef Induced Pulmonary Vasculopathy (Q58092671) (← links)
- Viral infection and atherosclerosis (Q59353210) (← links)
- HIV Proteins and Endothelial Dysfunction: Implications in Cardiovascular Disease (Q60946881) (← links)
- Pathogens and atherosclerosis: Update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis (Q82102394) (← links)
- Triad of the Ischemic Cardiovascular Disease in People Living with HIV? Association Between Risk Factors, HIV Infection, and Use of Antiretroviral Therapy (Q88733762) (← links)
- Drug abuse and HIV-related pulmonary hypertension: double hit injury (Q91573974) (← links)
- Effects of HIV-1 gp120 and TAT-derived microvesicles on endothelial cell function (Q91789997) (← links)
- In-vivo MRI Reveals Changes to Intracerebral Vasculature Caliber in HIV Infection (Q91811307) (← links)